The XOMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XOMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The XOMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View XOMA Detailed Price Forecast - CNN Money||View XOMA Detailed Summary - Google Finance|
|View XOMA Detailed Summary - Yahoo! Finance||View XOMA Stock Research & Analysis - Zacks.com|
|View XOMA Trends & Analysis - Trade-Ideas||View XOMA Major Holders - Barrons|
|View XOMA Call Transcripts - NASDAQ||View XOMA Breaking News & Analysis - Seeking Alpha|
|View XOMA Annual Report - CompanySpotlight.com||View XOMA OTC Short Report - OTCShortReport.com|
|View XOMA Fundamentals - TradeKing||View XOMA SEC Filings - Bar Chart|
|View Historical Prices for XOMA - The WSJ||View Performance/Total Return for XOMA - Morningstar|
|View the Analyst Estimates for XOMA - MarketWatch||View the Earnings History for XOMA - CNBC|
|View the XOMA Earnings - StockMarketWatch||View XOMA Buy or Sell Recommendations - MacroAxis|
|View the XOMA Bullish Patterns - American Bulls||View XOMA Short Pain Metrics - ShortPainBot.com|
|View XOMA Stock Mentions - StockTwits||View XOMA Stock Mentions - PennyStockTweets|
|View XOMA Stock Mentions - Twitter||View XOMA Investment Forum News - Investor Hub|
|View XOMA Stock Mentions - Yahoo! Message Board||View XOMA Stock Mentions - Seeking Alpha|
|View Insider Transactions for XOMA - SECform4.com||View Insider Transactions for XOMA - Insider Cow|
|View XOMA Major Holdings Summary - CNBC||View Insider Disclosure for XOMA - OTC Markets|
|View Insider Transactions for XOMA - Yahoo! Finance||View Institutional Holdings for XOMA - NASDAQ|
|View XOMA Stock Insight & Charts - FinViz.com||View XOMA Investment Charts - StockCharts.com|
|View XOMA Stock Overview & Charts - BarChart||View XOMA User Generated Charts - Trading View|
XOMA Added to the Russell 2000® and Russell 3000® Indexes
Posted on Tuesday June 26, 2018
XOMA Corporation (XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced the Company has been added to the Russell 2000® and Russell 3000® Indexes following the annual reconstitution, which took effect after the U.S. market closed on June 22, 2018. “We believe XOMA’s addition to these Russell indexes will enhance our visibility in the investment community and broaden our shareholder base,” stated Jim Neal, Chief Executive Officer at XOMA. The Russell 3000® Index is a market capitalization-weighted equity index that tracks the performance of the largest 3,000 U.S. stocks.
XOMA to Present at the UBS Global Healthcare Conference
Posted on Tuesday May 15, 2018
XOMA Corporation (XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present the Company’s royalty-aggregator business model at the UBS Global Healthcare Conference on Tuesday, May 22, 2018, at 1:00 p.m. ET. A live audio webcast of the presentation can be accessed in the Investors section of XOMA's website at www.xoma.com. XOMA has built a portfolio of over two dozen products that are licensed to and being developed by other biotech and pharmaceutical companies.
Xoma: 1Q Earnings Snapshot
Posted on Wednesday May 09, 2018
The Berkeley, California-based company said it had a loss of 46 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
XOMA Reports First Quarter 2018 Financial Results
Posted on Wednesday May 09, 2018
EMERYVILLE, Calif., May 09, 2018-- XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced its first quarter 2018 financial results.. “Our efforts ...